文献

J-GLOBAL ID：201702244701663982   整理番号：17A0960955

ベースライン総前立腺特異抗原<2.0ng/mLの男性における異なる前立腺特異抗原に基づくマーカーの予測価値

Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL

著者 (9件)： Fujizuka Yuji (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Ito Kazuto (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Oki Ryo (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Suzuki Rie (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Sekine Yoshitaka (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Koike Hidekazu (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Matsui Hiroshi (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Shibata Yasuhiro (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan) ,  Suzuki Kazuhiro (Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan)
資料名： International Journal of Urology (Web)  (International Journal of Urology (Web))
巻： 24  号： 8  ページ： 602-609  発行年： 2017年 
JST資料番号： U0707A  ISSN： 1442-2042  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： 目的:ベースライン総前立腺特異抗原<2.0ng/mLの男性に...

シソーラス用語： 前立腺特異抗原 ,...
準シソーラス用語： *予後予測 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0960955&from=J-GLOBAL&jstjournalNo=U0707A") }}

著者キーワード (5件)： free prostate-specific antigen ,  proprostate-specific antigen ,  prostate cancer ,  prostate-specific antigen ,  screening

分類 (3件)： 腫ようの診断  (GE03020J) ,  泌尿生殖器の腫よう  (GM04000S) ,  抗原・抗体・補体の生化学  (ED04020L)

引用文献 (23件)：

• Center MM, Jemal A, Lortet-Tieulent J et al. International variation in prostate cancer incidence and mortality rates. Eur. Urol. 2012; 61: 1079-92.
• Ito K. Prostate cancer in Asian men. Nat. Rev. Urol. 2014; 11: 197-212.
• Schröder FH, Hugosson J, Roobol MJ et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 2014; 384: 2027-35.
• Hugosson J, Carlsson S, Aus G et al. Mortality results from the Göteborg randomized population - based prostate - cancer screening trial. Lancet Oncol. 2010; 11: 725-32.
• Ito K, Raaijmakers R, Roobol M, Wildhagen M, Yamanaka H, Schröder FH. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening. Cancer 2005; 103: 242-50.

タイトルに関連する用語 (7件)： ベースライン ,  前立腺特異抗原 ,  ML ,  男性 ,  マーカー ,  予測 ,  価値